Robert E Bristow
Overview
Explore the profile of Robert E Bristow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
213
Citations
5488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francoeur A, Liao C, Johnson C, Argueta C, Tian C, Darcy K, et al.
Int J Gynecol Cancer
. 2025 Jan;
35(1):100013.
PMID: 39878271
Objective: The aim of this study was to examine disparities in 20-year incidence trends and mutations in advanced-stage uterine cancer in the United States, given poor survival rates. Methods: Data...
2.
Francoeur A, Liao C, Chang J, Johnson C, Clair K, Tewari K, et al.
Obstet Gynecol
. 2025 Jan;
145(3):e107-e116.
PMID: 39746203
Objective: To evaluate the correlation in temporal trends in obesity and endometrioid endometrial cancer incidence in the United States using two comprehensive national databases. Methods: This is a cohort study...
3.
Clair K, Wolford J, Zell J, Bristow R
Hematol Oncol Clin North Am
. 2024 Nov;
39(1):67-87.
PMID: 39510678
This article addresses the role of surgery in the management of gynecologic cancers with liver metastases. The authors review the short-term and long-term outcomes of aggressive resection through retrospective and...
4.
Kim J, Kim S, Park E, Ha H, Kim J, Coleman R, et al.
Gynecol Oncol
. 2024 Nov;
179:24-32.
PMID: 39491079
Background: Current treatment strategies for primary epithelial ovarian cancer (EOC) have significantly evolved, and the value of complete cytoreduction has not yet been reassessed. The study aimed to investigate the...
5.
Rodriguez V, Tanjasiri S, Ro A, Hoyt M, Bristow R, LeBron A
Am J Epidemiol
. 2024 Jul;
194(1):103-113.
PMID: 38960701
Endometrial cancer is one of few cancers that has continued to rise in incidence over the past decade, with disproportionate increases in adults younger than 50 years old. We used...
6.
Pappa C, Galaal K, Smyth S, Bristow R, Khashan A, Alazzam M
Cochrane Database Syst Rev
. 2024 Jun;
6:CD015297.
PMID: 38934360
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone...
7.
Hari A, Chang J, Villanueva C, Ziogas A, Vieira V, Bristow R
Gynecol Oncol
. 2024 Feb;
184:123-131.
PMID: 38309029
Objective: To quantify the impact on short-term ovarian cancer survival associated with treatment at high-performing hospitals using the observed-to-expected ratio (O/E) for adherence to ovarian cancer treatment guidelines as a...
8.
Bristow R, Tomacruz R, Armstrong D, Trimble E, Montz F
J Clin Oncol
. 2023 Aug;
41(25):4065-4076.
PMID: 37643543
Purpose: To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy. Materials...
9.
Kumar P, Del Rosario M, Chang J, Ziogas A, Jafari M, Bristow R, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900256
Purpose: We analyzed adherence to the National Comprehensive Cancer Network treatment guidelines for anal squamous cell carcinoma in California and the associated impacts on survival. Methods: This was a retrospective...
10.
Kim S, Kim J, Lee S, Cho H, van Driel W, Sonke G, et al.
Gynecol Oncol
. 2022 Oct;
167(3):547-556.
PMID: 36273925
Background: The value of hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of cytoreductive surgery (CRS) for epithelial ovarian cancer (EOC) is controversial and its use remains experimental in most national...